Results 121 to 130 of about 883,314 (350)
European experience on the practical use of levosimendan in patients with acute heart failure syndromes [PDF]
, 2005 The novel calcium sensitizer and ATP-dependent potassium channel opener levosimendan has been introduced for routine use in several European countries. Recent reports on clinical experience confirm the positive hemodynamic results and beneficial clinical
Cardoso, JS, Follath, F, Franco, F
core +1 more source
Cardiology and TherapyCardiogenic shock is the most common cause of mortality in patients with acute myocardial infarction (AMI). Historically, AMI complicated by cardiogenic shock was associated with in-hospital survival of only ~50%.
Duc M. Giao, Robert P. Giugliano
doaj +1 more source
SCAI clinical expert consensus statement on the classification of cardiogenic shock
Catheterization and cardiovascular interventions, 2019 The outcome of cardiogenic shock complicating myocardial infarction has not appreciably changed in the last 30 years despite the development of various percutaneous mechanical circulatory support options.
D. Baran +13 more
semanticscholar +1 more source
Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction
ESC Heart Failure, EarlyView.Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino +5 more
wiley +1 more source
Are There Options to Prevent Early Occurring Deaths in Acute Myocardial Infarction: Prospective Evaluation of All < 24 h In-Hospital Deaths, 2004-2006-The MONICA/KORA Augsburg Infarction Registry [PDF]
, 2010 Objectives: To provide valid clinical data of early in-hospital deaths with presumed acute myocardial infarction (AMI) who are often not included in clinical trials or registries.
Ehmann, Anja +5 more
core +1 more source
ESC Heart Failure, EarlyView.Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner +9 more
wiley +1 more source
ESC Heart Failure, EarlyView.The ABDOPOCUS‐HF trial is a randomized, single‐blind, low‐intervention clinical trial (n = 168) investigating the utility of intra‐abdominal pressure (IAP) and point of care ultrasound to guide decongestive therapies during the first 72 hours after admission for acute heart failure.
C. Josa‐Laorden +20 more
wiley +1 more source
Coxsackie B2 Virus Infection Causing Multiorgan Failure and Cardiogenic Shock in a 42-Year-Old Man [PDF]
, 2019 Infections from coxsackie B2 viruses often cause viral myocarditis and, only rarely, multisystem organ impairment. We present the unusual case of a 42-year-old man in whom coxsackie B2 virus infection caused multiorgan infection, necessitating distal ...
Abdou, Mahmoud H. +2 more
core +1 more source
Cardiogenic shock: do not forget the possibility of Kawasaki disease
The Turkish Journal of Pediatrics, 2012 We report the case of a six-year-old boy who presented with cardiogenic shock due to Kawasaki disease (KD). He was misdiagnosed at first as septic shock.
Wei Wang +4 more
doaj
Clinical outcomes following shock team implementation for cardiogenic shock: a systematic review
The Egyptian Heart JournalBackground Cardiogenic shock is a critical cardiac condition characterized by low cardiac output leading to end-organ hypoperfusion and associated with high in-hospital mortality rates.
Mohamed Abdelnabi +6 more
doaj +1 more source